Latest news
-
AbSorber receives part of €2.6M EU grant in collaboration with EUROSTAM
-
Olerup introduces new SBT Resolver DRB1 seqencing assay
-
University of Heidelberg becomes a reference laboratory for XM-ONE®
-
Rush University Medical Center and AbSorber Enter Into a Collaborative Validation Study
Suppliers
News
AbSorber receives part of €2.6M EU grant in collaboration with EUROSTAM
2013-02-01The EUROSTAM consortium, with AbSorber AB as one of the collaborators, has been granted € 2.6M for developing a strategy to enhance the transplantation of highly sensitized patients The EUROSTAM consortium has been supported by a € 2.6M grant as part of the European Commission 7th framework programme (FP7). The main objective of the three year project is to determine the feasibility and advantage of implementing a Europe-wide acceptable mismatch program to facilitate transplantation of highly sensitized patients all over Europe.
Olerup introduces new SBT Resolver DRB1 seqencing assay
2012-12-21This new single tube PCR assay has intronic primers located in intron 1 and intron 2. Furthermore, this assay includes PCR primers for exon 3 and a sequencing primer that enables the resolution of common DRB1*03,12,13 and 14 ambiguities. Additional sequencing primers can be added as required. With Conexio’s large panel of HARPS, this HLA-DRB1 assay matches the typing resolution of GSA approaches to SBT of HLA-DRB1 but without the need for large amounts of DNA and PCR’s. The assay is currently available as RUO. CE IVD will follow in the first quarter of 2013.
University of Heidelberg becomes a reference laboratory for XM-ONE®
2012-11-14AbSorber announces that Abteilung Transplantationsimmunologie at Institut für Immunologie, Universität Heidelberg, Germany now operates as a reference laboratory for XM-ONE® testing in Germany and other European countries. The collaboration was initiated in October and the laboratory has now finalized the local validation of XM-ONE®. Fellow laboratories in Germany are now being informed about this opportunity to use the first available CE-marked test detecting anti-endothelial cell antibodies.
Rush University Medical Center and AbSorber Enter Into a Collaborative Validation Study
2012-09-18AbSorber announces they have entered into a pilot validation study in collaboration with Rush University Medical Center, one of the busiest transplantation centers in Chicago, IL, to investigate other potential clinical uses of the endothelial precursor cells isolated using the endothelial cell crossmatch XM-ONE®. Currently, XM-ONE® allows detection of non-HLA antibodies by flow cytometry. This proposed validation study will evaluate whether endothelial precursor cells could provide clinically relevant information about non-HLA antibodies when used together in a traditional cytotoxicity crossmatch assay in renal transplantation.
University of Miami initiates clinical trial of XM-ONE®
2012-06-07The transplantation unit at Jackson Memorial Hospital and the University of Miami, FL, USA has entered into a research project with AbSorber. The project is a pilot study evaluating the endothelial cell cross match XM-ONE® in their Living Donor program. University of Miami will investigate if antibodies detected by XM-ONE® will affect the outcome for the individual patient, in pre- and post-transplant situations.
Olerup introduces new Typing Kits at EFI
2012-06-05Olerup SSP AB presented its new products during the annual EFI meeting in Liverpool, UK. Main focus was on the new extended format of the company's low resolution typing kits as wella s on the new Olerup SSP Add ons, a new product line focusing on ambiguity solution complementary to other typing techniques such as SBT and SSO.
Tulane starts a prospective trial of XM-ONE® in Kidney Transplantation
2012-05-29Tulane University Hospital, New Orleans, LA will in May start a prospective trial in Kidney Transplantation investigating the potential of Absorber’s cross match XM-ONE® as part of the risk assessment in their patients.
Olerup SSP AB improves results of low resolution typing
2012-04-04Olerup SSP achieves improved low resolution typing results through minimizing ambiguities with format expansion. Olerup SSP AB has recently performed a significant format change in the low resolution typing kits. The new low resolution format configurations are a result of the evolving world of HLA and the increase in the number of detected alleles.
Clinical Use of XM-ONE in focus at ASHI symposium
2011-10-31Clinical use of XM-ONE® was highlighted at a symposium at the annual American Society of Histocompatibility and Immunogetetics (ASHI) meeting in New Orleans
Olerup presented the extended HLA typing portfolio at this year’s ASHI
2011-10-31At the recently held ASHI meeting in New Orleans, Allenex subsidiary Olerup SSP and AbSorber hosted two lunch symposiums. Conexio presented the now extended HLA typing portfolio distributed in the US by Olerup Inc. The focus of the symposium was the recently signed global distribution agreement between Conexio and Olerup SSP. Through the agreement Olerup SSP acquired the distribution and marketing rights for the Conexio SBT Resolver™ product line which includes locus specific assays for HLA. Olerup SSP and Olerup Inc. are both part of Allenex Group.
New study confirms that XM-ONE® identifies kidney transplant recipients at increased risk for acute rejection.
2011-05-11New study confirms that XM-ONE® identifies kidney transplant recipients at increased risk for acute rejection.
CONEXIO SBT Resolver™ product line is now distributed by Olerup, ensuring a high level of service and flexibility towards the HLA community
2011-05-10From May 1, 2011, Olerup has the distribution and marketing rights for the CONEXIO SBT product line. Thereby Olerup will be able to further increase focus and service towards the HLA community. In addition Olerup also distributes Olerup SSP® HLA typing products within this segment.
CONEXIO SBT Resolver™ product line is now distributed by Olerup, ensuring a high level of service and flexibility towards the HLA community
2011-05-10From May 1, 2011, Olerup has the distribution and marketing rights for the CONEXIO SBT product line. Thereby Olerup will be able to further increase focus and service towards the HLA community. In addition Olerup also distributes Olerup SSP® HLA typing products within this segment.
AbSorber to host a Scientific Symposium at the American Transplant Congress in Philadelphia, PA
2011-04-10AbSorber to host a Scientific Symposium at the American Transplant Congress in Philadelphia, PA
Olerup SSP’s HLA typing kits enters the Brazilian market
2011-02-10AbSorber and Olerup SSP has signed an exclusive distribution agreement for the Brazilian market, the world's second largest transplantation market after the US. Partner in Brazil is Genese Produtos Diagnosticos Ltda in Sao Paulo.
AbSorber’s XM-ONE enters the Brazilian market
2011-02-10AbSorber and Olerup SSP has signed an exclusive distribution agreement for the Brazilian market, the world's second largest transplantation market after the US. Partner in Brazil is Genese Produtos Diagnosticos Ltda in Sao Paulo.
Olerup SSP® – Low frequency of typing ambiguities with Olerup SSP® kits
2010-10-01At the recently held ASHI meeting in Hollywood, FL, a study investigating the frequency of typing ambiguities for low and high resolution SSP typings in two sets of samples was presented.The Olerup SSP® kits give excellent resolution for low and high resolution HLA typings with low ambiguity frequencies, but the kits have to be constantly and frequently up-dated for new HLA alleles in order to maintain this level of resolution.
Olerup SSP® kits show low frequency of typing ambiguities
2010-09-17Olerup SSP holds a symposium at the upcoming ASHI meeting in Hollywood, Florida
2010-08-31
AbSorber has submitted a 510K to the FDA (U.S. Food and Drug Administration) for a new version of the Company’s transplantation crossmatch, XM-ONE®. This new version has the potential to replace current flow Cytometry based crossmatch tests.
AbSorber hosted a morning symposium at The Transplantation Society’s 13th International Congress in Vancouver, Canada.
2010-08-16AbSorber hosted a morning symposium at The Transplantation Society’s 13th International Congress in Vancouver, Canada.
Olerup SSP® widens the product line of Accessory Products
2010-06-29Olerup SSP® widens the product line of Accessory Products – The Olerup SSP® GelRed™ Dropper Bottle “We are introducing the Olerup SSP® GelRed™ Dropper Bottle in order to provide the means to meet future demands of environmental and personnel safety and to increase flexibility for our customers" says Anna Hedlund, Head of R & D, Olerup SSP AB.
Improving outcomes in kidney transplantation: Non-HLA antibodies and Enhanced Clinical Risk Assessment
2010-06-03Improving outcomes in kidney transplantation: Non-HLA antibodies and Enhanced Clinical Risk Assessment
2010-05-07
At the American Transplant Congress in San Diego the organizers held a workshop of the subject of Endothelial Cell Crossmatch.
Olerup SSP® Product Name Changes
2010-04-09The Olerup SSP® product line is adjusting to meet the HLA nomenclature designation changes that take effect April 1st, 2010. The following list describes the Olerup SSP® product name changes that reflect the new HLA nomenclature. Please observe that the product numbers are unchanged and that these product name changes will take place gradually.
Olerup SSP Covered Alleles updated
2010-04-08Olerup SSP AB provides a complete library of alleles which is constantly updated. The latest update from April 2010 is now available for downloading and printing.
The HLA Nomenclature shift; Olerup SSP SCORE 4.001.T meets the requirements
2010-04-01Olerup SSP AB has, in close cooperation with Professor Wolfgang Helmberg, updated SCORE to meet the requirements coming from the HLA Nomenclature shift. The nomenclature shift is introduced as of April 1st.
Olerup GmbH will present on Bangalore Workshop
2010-03-26Olerup GmbH will present their product line at a workshop held in Bangalore, India, August20-21. The workshop is arranged by Biotron Healthcare. During the workshop focus will be on key products such as Olerup-SSP typing kits, XM-ONE, an assay for determination of HLA and non-HLA antibodies prior to organ transplantation and Arrow, for automated isolation of Nucleic Acids and Cells for HLA tissue typing laboratories.
AbSorber strengthens the position on the US market by acquiring Olerup Inc.
2010-03-01AbSorber strengthen its position on the important US market by acquiring NorDiag’s share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
AbSorber strengthens the position on the US market by acquiring Olerup Inc.
2010-03-01AbSorber strengthen its position on the important US market by acquiring NorDiag’s share of Olerup Inc. AbSorber buys the company together with SSP Primers and after the transition will AbSorber own 50 percent of Olerup Inc. and SSP Primers 50 percent.
AbSorber receives European patent protection for its transplantation cross match-test XM-ONE®
2009-12-09AbSorber has received patent protection for its transplantation cross match-test XM-ONE® in the European countries. The patent was previously approved in New Zealand which was the first country to approve a patent for AbSorbers product.
Olerup SSP ready for the US
2009-09-15Olerup SSP has had its Taq-polymerase-free HLA typing kit registered and cleared by the FDA. This means that Olerup SSP’s entire product range for HLA typing, with or without Taq polymerase, can now be marketed and sold to a greater number of healthcare centers in North America. The U.S. is the single largest market for HLA typing and represents over 40 percent of the global tissue typing market. Olerup SSP’s HLA typing kit with Taq polymerase has been approved by the FDA for sale in the United States since March 2009.
Olerup SSP ready for the US
2009-09-15Olerup SSP has had its Taq-polymerase-free HLA typing kit registered and cleared by the FDA. This means that Olerup SSP’s entire product range for HLA typing, with or without Taq polymerase, can now be marketed and sold to a greater number of healthcare centers in North America. The U.S. is the single largest market for HLA typing and represents over 40 percent of the global tissue typing market. Olerup SSP’s HLA typing kit with Taq polymerase has been approved by the FDA for sale in the United States since March 2009.
Olerup International partners up with Nordiag
2009-07-06Global distribution company, Olerup International AB, that acquired the distribution rights for the Olerup SSP® product line including facilities and infrastructure associated with the products from Qiagen GmbH June 2009, will get the Norwegian biotech and diagnostic company NorDiag ASA as owner and partner.
Olerup International partners up with Nordiag
2009-07-06Global distribution company, Olerup International AB, that acquired the distribution rights for the Olerup SSP® product line including facilities and infrastructure associated with the products from Qiagen GmbH June 2009, will get the Norwegian biotech and diagnostic company NorDiag ASA as owner and partner.
AbSorber; New global distribution agreement for XM-ONE®
2009-07-02New global distribution partner effective from July 1, 2009. The new distributor, Olerup International, gives AbSorber the opportunity to sell XM-ONE® and future products globally with a highly specialized sales force within the Transplantation segment.
Strategic deal drives top-line growth
2009-07-02NorDiag ASA has today entered into a joint venture (JV) with LinkMed AB and SSP Primers AB. The JV will be in the form of a jointly owned company, named Olerup International AB, which will be owned 50% by NorDiag and 25% by LinkMed AB and SSP Primers AB respectively.
Strategic deal drives top-line growth
2009-07-02NorDiag ASA has today entered into a joint venture (JV) with LinkMed AB and SSP Primers AB. The JV will be in the form of a jointly owned company, named Olerup International AB, which will be owned 50% by NorDiag and 25% by LinkMed AB and SSP Primers AB respectively.
Olerup GmbH takes over in Vienna
2009-06-26From the 1st of July the new founded company Olerup GmbH will take over the office and all products related to Olerup SSP® from QIAGEN Vertriebs GmbH in Vienna.
Olerup GmbH takes over in Vienna
2009-06-26From the 1st of July the new founded company Olerup GmbH will take over the office and all products related to Olerup SSP® from QIAGEN Vertriebs GmbH in Vienna.
Olerup International takes over sales of Olerup SSP
2009-06-16From July 1, 2009, the new company, Olerup International AB, owned in collaboration with Olle Olerup, will be responsible for sales of the Olerup SSP product line within HLA typing.
Olerup International takes over sales of Olerup SSP
2009-06-16From July 1, 2009, the new company, Olerup International AB, owned in collaboration with Olle Olerup, will be responsible for sales of the Olerup SSP product line within HLA typing.
"Simple to use and straightforward"
2009-05-05Ron Shapiro, Professor of surgery at the Thomas E. Starzl Institute of University of Pittsburgh Medical Center discusses the recently published multicenter study of Absorbers’ endothelial crossmatch, XM-ONE, at a video blog at Medscape.com.
AbSorber’s transplantation crossmatch test strong predicator for acute rejections – study published in prestigious international medical journal
2009-03-02AbSorber’s transplantation crossmatch test XM-ONE® was evaluated in a large clinical study and the results are now published in the prestigious international medical journal Transplantation.
AbSorber launches transplantation crossmatch test in U.S. at conference and strengthens financial
2008-10-27AbSorber will kick-off the U.S. launch of its transplantation crossmatch test XM-ONE® at the ASHI annual meeting in Toronto. XM-ONE® received FDA registration in August 2008.
AbSorber receives its first patent for the transplantation crossmatch test XM-ONE®
2008-10-21AbSorber has received patent protection for the transplantation crossmatch test XM-ONE® in New Zealand. New Zealand is thereby the first country to approve a patent for AbSorber’s product.
2008-08-18
The Swedish biotech company AbSorber recently received FDA approval in the U.S. for its patented transplantation test XM-ONE®. Now AbSorber has received further support for its transplantation test from a major clinical trial in which six well-reputed...
2008-08-12
The Swedish biotech company AbSorber has been given clearance by the U.S. Food and Drug Administration (FDA) to market and sell its XM-ONE® transplantation test in the U.S. Initially, sales of XM-ONE® in the U.S. will target the kidney transplantation...
Anders Karlsson new CEO of AbSorber
2008-04-17Anders Karlsson has been appointed the new CEO of the transplantation company AbSorber. Karlsson has been COO of the company since the fall. AbSorber’s former CEO Ingemar Lagerlöf is taking on the role of member of the board of AbSorber.
2008-04-08
LinkMed’s portfolio company AbSorber has been granted a patent in the U.S. for an AB0 column that the company is developing to facilitate transplantations between individuals of different blood groups.
2007-09-10
AbSorber is pleased to announce the appointment of Anders Karlsson as Chief Operating Officer (COO). Karlsson joins AbSorber from Novartis, where he was CEO for the company’s operations in Norway.
AbSorber develops AB0 diagnostic test
2007-03-28AbSorber AB, launched its first product, XM-ONE, at the end of 2006. AbSorber’s next product – an AB0 diagnostic test – was presented at a conference on AB0 incompatible transplantation outside Stockholm.
Camilla Tell Järte new Medical/Marketing Manager
2007-03-27AbSorber AB has appointed Camilla Tell Järte as Medical/Marketing Manager. In this capacity, Camilla will mainly be engaged in the marketing of XM-ONE. She will also play an important role in the planning process for AbSorbers coming product portfolio.
AbSorber partners with BD for novel transplantation cross match test
2006-11-23The Swedish biotech company AbSorber has entered into an agreement with BD (Becton, Dickinson and Company) regarding XM-ONE, AbSorber’s novel CE-marked transplantation cross match test kit.
